Going All In on mRNA, Sanofi Breaks Ground on New Vaccine Site

Going All In on mRNA, Sanofi Breaks Ground on New Vaccine Site

Source: 
BioSpace
snippet: 

On Monday, Sanofi laid the first stone in the construction of its Evolutive Vaccine Facility, which is expected to be a fully digitalized production site the company believes will “transform the way we make vaccines and treatments.”

In addition to the beginning of construction, Sanofi announced an investment of more than $1 billion into the development of new mRNA programs.